In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of this dangerous skin cancer that renders promising treatments ineffective.
Health Professionals
Black Patients Have the Highest Mortality Risk For Melanoma of the Head and Neck
Black patients have the highest disease-specific mortality risk among patients with cutaneous melanoma of the head and neck, according to study findings published in the Journal of the American Academy of Dermatology.
SkylineDx Data Confirms Accuracy of the Merlin Test for Low- and High-Risk Melanoma
Results from Society for Melanoma Research Congress demonstrated excellent predictive power of noninvasive CP-GEP Merlin test.
Melanoma cells use apolipoprotein E to evade ferroptosis, study finds
A research team led by Prof. Patrizia Agostinis (VIB-KU Leuven) has found that melanoma cell populations protect themselves from a form of cell death called ferroptosis by secreting the lipoprotein apolipoprotein E (ApoE). Their work appears in Science Advances.